MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Can Square Wave Jerks Differentiate Progressive Supranuclear Palsy from Parkinson’s Disease? A Scoping Review

    Y. Xu, N. Bellacicco, E. Feinstein (Newark, USA)

    Objective: To review the available literature regarding the presence and properties of square wave jerks (SWJs) in Progressive Supranuclear Palsy (PSP) and Parkinson’s Disease (PD).…
  • 2024 International Congress

    Comprehensive Strategy for Increasing Clinical Research Participation of Black and Hispanic Patients with Parkinsonism

    D. Quintana Mora, Y. Mendez, A. Cervera, J. Crary, R. Walker, M. Nirenberg (New York, USA)

    Objective: To implement and test a multidimensional strategy for increasing racial and ethnic diversity in parkinsonism research. Background: Diversity in research participation is critical for…
  • 2024 International Congress

    Pregnancy and delivery in women with Parkinson’s disease: A case series

    W. Kapelle, A. Oosterbaan, G. Patané, C. Piat, K. Ghoniem, E. Camerucci, P. Turcano, J. Bower, R. Savica (Rochester, USA)

    Objective: To explore pregnancy, delivery, birth outcomes and disease course throughout pregnancy  in women with Early Onset Parkinson’s disease (EOPD) who underwent pregnancy after onset…
  • 2024 International Congress

    A Risk of Thromboembolic Complications In Patients With Parkinson’s Disease

    P. Lisewski, B. Lisewska, N. Słomka, M. Wasilewska, D. Rość (Bydgoszcz, Poland)

    Objective: A small number of reports refer to studies assessing the risk of thromboembolic complications in patients with PD in the form of a stroke,…
  • 2024 International Congress

    Sexual Dimorphism in Clinical Subtypes, Biomarkers and Disease Progression of Parkinson’s Disease

    SM. Fereshtehnejad, H. Azizi, J. Lökk, Y. Zeighami (Toronto, Canada)

    Objective: To investigate differences in clinical subtypes, biomarkers, and course of progression in Parkinson’s disease (PD) between the two biological sexes. Background: PD is a…
  • 2024 International Congress

    The potential role of monocytes a-synuclein and lipids as predictors of PD.

    S. Lucas-Del-Pozo, G. Uras, D. Moreno-Martinez, F. Fierli, S. Koletsi, C. Manis, P. Caboni, D. Hughes, A. Schapira (London, United Kingdom)

    Objective: To study the role monocytic A-syn and lipids as biomarkers of PD. Background: A chronic pro-inflammatory pattern is present in Parkinson’s disease (PD) patients’…
  • 2024 International Congress

    Deep Brain Stimulators in Parkinson`s subthalamic nucleus: A Study of Decade Follow-Up

    L. Neerati, V. Raju, G. Ramaraju (Hyderabad, India)

    Objective: To analyze the motoric and non-motoric symptoms of Parkinson`s following subthalamic-nuclei deep brain stimulations from a decade of follow-up study. Background: From the rudiment…
  • 2024 International Congress

    A UK-wide Effort for Identification of Loci for Autosomal Dominant Parkinson’s Disease

    R. Tilney, R. Real, S. Jasaityte, Z. Fang, M. Fenn, L. Lange, A. Singleton, C. Blauwendraat, C. Klein, H. Morris, GP2. Genetic Program (London, United Kingdom)

    Objective: (i) To describe the demographic, clinical and genetic features of a large cohort of familial autosomal dominant Parkinson’s disease (PD) patients in the UK.(ii)…
  • 2024 International Congress

    the role of metabotropic glutamate receptors type 3 and 5 in parkinson’s disease: analysis of grm3 and grm5 genbe variants.

    M. Alborghetti, E. Bianchini, D. Rinaldi, I. de Bartolo, L. Di Menna, G. Battaglia, V. Bruno, T. Esposito, M. Borro, M. Simmaco, F. Pontieri, A. Berardelli, F. Nicoletti (Rome, Italy)

    Objective: The aim of the study was to examine the association between polymorphic variants of GRM3 and GRM5 and Parkinson’s disease (PD) and motor and…
  • 2024 International Congress

    Determining and Leveraging Local Ancestry to Assess Individual-Level Risk: from the Global Parkinson’s Genetics Program

    G. Parkinson'S_genetics_program (gp2) (Bethesda, USA)

    Objective: We develop a scalable pipeline leveraging existing tools to determine local ancestry for all individuals in the Global Parkinson’s Genetics Program (GP2), aiming to…
  • « Previous Page
  • 1
  • …
  • 525
  • 526
  • 527
  • 528
  • 529
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley